Sumitomo Pharma Co Ltd – Notice regarding withdrawal of shelf registration statement for issuance of new shares – Charm

Delayed Japan Exchange			5-day change	1st Jan Change
1,950.50 ^JPY	-5.36%		-5.91%	-15.85%

Published on 04/26/2026
at 10:41 pm EDT

Reuters

Duration

Period

Sumitomo Pharma Co Ltd, formerly Sumitomo Dainippon Pharma Co Ltd, is a Japan-based pharmaceutical company. The Company operates its business through four segments. The Japan segment is engaged in the manufacture, purchase, and sale of ethical drugs. The North American segment is engaged in the manufacture, purchase, and sale of ethical drugs and conducts research and development in the areas of oncology, urology, respiratory disease, and regenerative cell medicine. The China segment is engaged in the manufacture (small packaged products) and sale of ethical pharmaceuticals. The Overseas Others segment is engaged in the manufacture and sale of ethical pharmaceuticals in Europe. The segment also purchase and sell ethical pharmaceuticals in Southeast Asia and Taiwan, as well as provide information and collection activities for the Company’s products. Other business includes manufacturing, purchasing, and sales of food ingredients, food additives and chemical product materials.